Endometrial arteriogenesis: Vascular smooth muscle cell proliferation and differentiation during the menstrual cycle and changes associated with endometrial bleeding disorders
- 3 February 2003
- journal article
- review article
- Published by Wiley in Microscopy Research and Technique
- Vol. 60 (4) , 412-419
- https://doi.org/10.1002/jemt.10279
Abstract
The cyclical regrowth of the human endometrial vasculature every 28 days following menstruation provides an excellent opportunity for studying arteriogenesis in a human tissue. Despite this, very little has been published to date about temporal or spatial changes in endometrial arteriolar structure or function. Immunohistochemical studies using vascular smooth muscle cell (VSMC) differentiation markers have identified spatially organised differences in VSMC phenotype. However, these have not significantly increased our understanding of how or when arteriogenesis occurs. Endometrial VSMC proliferation continues at a steady rate throughout the cycle, increasing in the specialised spiral arterioles in the mid and late secretory phases. Although estrogen and progesterone play a dominant role in regulating endometrial growth and regression, their direct involvement in arteriogenesis is less clear. Estrogen and progesterone receptors have been reported in endometrial VSMC, although heterogeneity of expression occurs. The angiopoietin/Tie axis has been investigated in endometrium, although the results of 3 studies published to date are contradictory, making conclusions about a role in arteriogenesis problematic. Abnormalities of arteriogenesis may play a role in disorders such as menorrhagia and breakthrough bleeding in contraceptive and hormone replacement therapy users. There is evidence that VSMC proliferation is reduced in spiral arterioles of women with menorrhagia, along with reduced pulsatility index of the uterine artery as shown by Doppler ultrasound. In women taking progestin-only contraception, endometrial perivascular alpha smooth muscle actin is reduced in those who suffer from breakthrough bleeding compared to those that don't. Considerable work is still required to elucidate when in the cycle, where in the tissue, and what mechanisms regulate endometrial arteriogenesis. Microsc. Res. Tech. 60:412–419, 2003.Keywords
This publication has 52 references indexed in Scilit:
- Down-Regulation of Angiopoietin-1 Expression in MenorrhagiaThe American Journal of Pathology, 2002
- Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator ReceptorJournal of Clinical Endocrinology & Metabolism, 2001
- Expression of Angiopoietin-2 by Human Endometrial Endothelial Cells: Regulation by Hypoxia and InflammationBiochemical and Biophysical Research Communications, 2000
- Endometrial microvascular growth in normal and dysfunctional statesHuman Reproduction Update, 1998
- Transforming growth factor-β1in the human endometriumGynecological Endocrinology, 1996
- Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue: localization and in vitro actionEndocrinology, 1992
- Angiogenesis in the postovulatory primate endometrium: The coiled arteriolar systemThe Anatomical Record, 1989
- A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.The Journal of cell biology, 1986